BioStock: Saniona´s obesity drug one step closer to approval

The Mexican regulatory authority technical committee on new molecules has provided a favourable opinion on Saniona´s drug candidate tesofensine for the treatment of obesity. BioStock reached out to CEO Thomas Feldthus for a comment.

Read the full interview with Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2023/03/sanionas-obesity-drug-one-step-closer-to-approval/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/